Literature DB >> 22419544

Concise review: Immune recognition of induced pluripotent stem cells.

Ashleigh S Boyd1, Neil P Rodrigues, Kathy O Lui, Xuemei Fu, Yang Xu.   

Abstract

Autologous-induced pluripotent stem cells (iPSCs) may eventually be used in cell replacement therapies to treat a wide range of diseases and have been touted as a solution to the vexing problem of immune rejection in this context. Emerging evidence suggests, however, that ostensibly histocompatible iPSCs may be rejected following transplantation. Here, we review the mechanisms that contribute to immunogenicity in iPSCs and forward approaches to permit their acceptance in potential cell replacement therapies.
Copyright © 2012 AlphaMed Press.

Mesh：

Year:  2012        PMID： 22419544     DOI： 10.1002/stem.1066

Source DB:  PubMed          Journal:  Stem Cells        ISSN： 1066-5099            Impact factor:   6.277


  29 in total

1.  Created equal? The many facets of cell reprogramming.

Authors:  Annarosa Leri; Jan Kajstura
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

Review 2.  Scaffolds and cells for tissue regeneration: different scaffold pore sizes-different cell effects.

Authors:  Ieva Bružauskaitė; Daiva Bironaitė; Edvardas Bagdonas; Eiva Bernotienė
Journal:  Cytotechnology       Date:  2015-06-20       Impact factor: 2.058

3.  Neonatal desensitization supports long-term survival and functional integration of human embryonic stem cell-derived mesenchymal stem cells in rat joint cartilage without immunosuppression.

Authors:  Shufang Zhang; Yang Zi Jiang; Wei Zhang; Longkun Chen; Tong Tong; Wanlu Liu; Qin Mu; Hua Liu; Junfeng Ji; Hong Wei Ouyang; Xiaohui Zou
Journal:  Stem Cells Dev       Date:  2012-08-14       Impact factor: 3.272

Review 4.  Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.

Authors:  S D Sackett; M E Brown; D M Tremmel; T Ellis; W J Burlingham; J S Odorico
Journal:  Transplant Rev (Orlando)       Date:  2016-02-10       Impact factor: 3.943

5.  Detection of Stem Cell Transplant Rejection with Ferumoxytol MR Imaging: Correlation of MR Imaging Findings with Those at Intravital Microscopy.

Authors:  Heike E Daldrup-Link; Carmel Chan; Olga Lenkov; Seyedmeghdad Taghavigarmestani; Toktam Nazekati; Hossein Nejadnik; Fanny Chapelin; Aman Khurana; Xinming Tong; Fan Yang; Laura Pisani; Michael Longaker; Sanjiv Sam Gambhir
Journal:  Radiology       Date:  2017-01-27       Impact factor: 11.105

6.  An effective approach to prevent immune rejection of human ESC-derived allografts.

Authors:  Zhili Rong; Meiyan Wang; Zheng Hu; Martin Stradner; Shengyun Zhu; Huijuan Kong; Huanfa Yi; Ananda Goldrath; Yong-Guang Yang; Yang Xu; Xuemei Fu
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

Review 7.  Magnetic resonance imaging of stem cell-macrophage interactions with ferumoxytol and ferumoxytol-derived nanoparticles.

Authors:  Hossein Nejadnik; Jessica Tseng; Heike Daldrup-Link
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-02-07

Review 8.  Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability.

Authors:  Xuemei Fu; Yang Xu
Journal:  Genome Med       Date:  2012-06-28       Impact factor: 11.117

9.  Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells.

Authors:  Pengfei Liu; Shubin Chen; Xiang Li; Li Qin; Ke Huang; Lihui Wang; Wenhao Huang; Shengbiao Li; Bei Jia; Mei Zhong; Guangjin Pan; Jinglei Cai; Duanqing Pei
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1.

Authors:  Vanessa Kruse; Carina Hamann; Sebastian Monecke; Lukas Cyganek; Leslie Elsner; Daniela Hübscher; Lutz Walter; Katrin Streckfuss-Bömeke; Kaomei Guan; Ralf Dressel
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.